Cite Filings / WVE / 0001193125-19-074933
Feed Companies Filings Check
Sign in
SC 13D/A

Beneficial Ownership Report

Wave Life Sciences, Inc. · Filed 2019-03-14 · Acc 0001193125-19-074933

Documents 1

  • SC 13D/A Beneficial Ownership Report , d700787dsc13da.htm

Around this filing

  • 2021-08-18 SC 13D/A Beneficial Ownership Report
  • 2019-03-14 SC 13D/A Beneficial Ownership Report
  • 2019-03-11 4 Chief Financial Officer acquired 13,500 shares (grant or award)
  • 2019-03-11 4 Franchise Lead, Neurology sold 7,000 shares at $48.00 ($336,000)
  • 2019-03-11 4 President and CEO acquired 60,000 shares (grant or award)
  • 2019-03-11 4 Francis Chris acquired 13,500 shares (grant or award)
  • 2019-02-20 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Maverick Capital, Ltd. 0.0%
  2. 2024-02-13 SC 13G/A · BB Biotech AG 3.7%
  3. 2023-02-14 SC 13G/A · BB Biotech AG 5.2%
  4. 2022-02-11 SC 13G/A · BB Biotech AG 7.8%
  5. 2021-02-12 SC 13G/A · BB Biotech AG 5.3%
  6. 2020-02-14 SC 13G/A · BB Biotech AG 7.0%
  7. 2019-12-23 SC 13G · BB Biotech AG 5.5%
Loading d700787dsc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…